B. Bergström

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Jean‐Jacques Body, Ingo Diel, E.D. Kreuser et al. · Annals of Oncology · 2003 · 414 citations · Full text

Bone Disease, Bone Health, Skeletal Complications +11

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

Jean‐Jacques Body, Ingo Diel, M. Lichinitzer et al. · British Journal of Cancer · 2004 · 334 citations · Full text

Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer

Jean-Jacques Body, Ingo Diel, Richard H. Bell et al. · Pain · 2004 · 189 citations

Cancer Quality, Pain Therapy, Pain Medicine +17

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

Ingo Diel, Jean‐Jacques Body, E.D. Kreuser et al. · European Journal of Cancer · 2004 · 164 citations

Bone Disease, Bone Health, Oncology +9

Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial

Debu Tripathy, M. Lichinitzer, A. F Lazarev et al. · Annals of Oncology · 2004 · 100 citations

Bone Disease, Breast Oncology, Medicine +9